| 标题 |
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Ziming Li; Yan Wang; Yuping Sun; Linlin Wang; Xingya Li; et al 出版日期:2025-02-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)